[FURL=https://www.industryarc.com/Research/Therapeutic-Nuclear-Medicines-Sales-Market-Research-508286?utm_source=briefingwire&utm_medium=pressrelease&utm_campaign=paidpressrelease]Therapeutic Nuclear Medicines Sales Market[/FURL] size is estimated at $1.6 billion in 2020, projected to grow at a CAGR of 7.3% during the forecast period 2021-2026. Therapeutic Nuclear Medicine is a pharmaceutical formulation containing radioactive materials. Cancer, metastatic bone tumors, and other disorders are treated with therapeutic nuclear medicines. Therapeutic nuclear drugs contain radioactive material that can destroy cancerous tissue, shrink tumors, and alleviate pain. Alpha Emitters, Beta Emitters and Brachytherapy Isotopes are the various types of therapeutic nuclear medicines.Key Takeaways
The growing need for early and reliable diagnosis, as well as the increasing demand for better medical solutions around the globe, is expected to drive demand for Therapeutic Nuclear Medicines Sales Industry.
Geographically, North America Therapeutic Nuclear Medicines Sales Market held the largest revenue share of 37% in 2020 owing to the involvement of potential players who are developing innovative products, high investments in R&D and support of government towards the use of medical isotopes investments in healthcare.
The Therapeutic Nuclear Medicines Sales Industry is being driven by the growing geriatric population and increased understanding of nuclear medicines and molecular imaging.
Furthermore, radiopharmaceuticals are widely used in molecular imaging, a method in which molecules are used as biomarkers for complex molecular processes that decide the initiation and/or progression of disease driving the demand for Therapeutic Nuclear Medicines Sales Industry.
Download Sample Report @ [FURL]https://www.industryarc.com/pdfdownload.php?id=508286[/FURL]
Therapeutic Nuclear Medicines Sales Market Segment Analysis - By Geography
Based on Geography, North America Therapeutic Nuclear Medicines Sales Market accounted for the 37% revenue share in 2020 owing to the existence of streamlined healthcare facilities, higher levels of individual understanding, and a wide range of treatment choices like radiopharmaceutical, alpha emitters & beta emitters to choose from are all factors that contribute to its large revenue share. Pharmaceutical companies and government organizations are forming strategic alliances in the region, especially to develop generic drugs and raise awareness among healthcare professionals.
Therapeutic Nuclear Medicines Sales Market - Drivers
The Use Of Radiopharmaceuticals For Therapeutic Purposes Is Gaining Popularity
Therapeutic Nuclear Medicines Sales Market - Landscape
Therapeutic Nuclear Medicines Sales Market top 10 companies are Cardinal Health, Eckert & Ziegler, Curium Pharma, International Isotopes Idaho, Inc., Medi-Radiopharma Co., Ltd., Novartis AG, Orano, Isoray Inc., Jubilant Pharma, Progenics Pharmaceuticals and Theragenics Corporation.
About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.